Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1D | P25100 | 1/20 | 1.00 |
| ▸ | PTAFR | P25105 | 1/20 | 1.00 |
| ▸ | HTR1D | P28221 | 1/20 | 1.00 |
| ▸ | HTR2C | P28335 | 1/20 | 1.00 |
| ▸ | ADRA1B | P35368 | 1/20 | 1.00 |
| ▸ | DRD3 | P35462 | 1/20 | 1.00 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.76 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.76 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.76 |
| ▸ | PRKCG | P05129 | 1/20 | 0.76 |
| ▸ | PRKCB | P05771 | 1/20 | 0.76 |
| ▸ | PRKCA | P17252 | 1/20 | 0.76 |
| ▸ | PRKCH | P24723 | 1/20 | 0.76 |
| ▸ | AKT1 | P31749 | 1/20 | 0.76 |
| ▸ | PRKCI | P41743 | 1/20 | 0.76 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.76 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.76 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30655807 | 1.00 | ADRA1D (1.00) | ADRA1DPTAFRHTR1DHTR2CADRA1B | |
| SCHEMBL30652762 | 1.00 | ADRA1D (1.00) | ADRA1DPTAFRHTR1DHTR2CADRA1B | |
| SCHEMBL30652521 | 1.00 | ADRA1D (1.00) | ADRA1DPTAFRHTR1DHTR2CADRA1B | |
| SCHEMBL34464893 | 1.00 | ADRA1D (1.00) | ADRA1DPTAFRHTR1DHTR2CADRA1B | |
| SCHEMBL435191 | 1.00 | ADRA1D (1.00) | ADRA1DPTAFRHTR1DHTR2CADRA1B | |
| Platelet Activating Factor SCHEMBL2734461 | 1.00 | ADRA1D (1.00) | ADRA1DPTAFRHTR1DHTR2CADRA1B | |
| SCHEMBL2534238 | 1.00 | ADRA1D (1.00) | ADRA1DPTAFRHTR1DHTR2CADRA1B | |
| SCHEMBL30366852 | 1.00 | ADRA1D (1.00) | ADRA1DPTAFRHTR1DHTR2CADRA1B | |
| SCHEMBL30650457 | 1.00 | ADRA1D (1.00) | ADRA1DPTAFRHTR1DHTR2CADRA1B | |
| Platelet Activating Factor SCHEMBL1392735 | 1.00 | ADRA1D (1.00) | ADRA1DPTAFRHTR1DHTR2CADRA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2781 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4434588-B1 | AEROSOL DELIVERY DEVICE | PARI PHARMA GMBH (DE) | 2026-04-08 | — | — | EP | claimed |
| EP-3551388-B1 | ABRASIVE ARTICLE AND METHOD OF GRINDING | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4684213-A1 | METHODS FOR ASSESSING PLATELET FUNCTION | University of Reading (GB) | 2026-01-28 | — | — | EP | claimed |
| US-20250295730-A1 | METHODS AND MATERIALS FOR MODULATING T CELL ACTIVATION USING TRAILshort POLYPEPTIDES | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2025-09-25 | — | — | US | claimed |
| US-20250275951-A1 | DRUGS TARGETING INFLAMMATION FOR THE TREATMENT OF OSTEOARTHRITIS AND OTHER INFLAMMATORY DISEASES | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | 2025-09-04 | — | — | US | claimed |
| US-12371438-B2 | Ginkgolide B derivative and salt thereof, preparation method therefor and use thereof | Huiling Jinxin (Shanghai) Pharmaceutical Technology Co., Ltd (CN) | 2025-07-29 | — | — | US | claimed |
| US-20250222189-A1 | Blood And Toxin Filter Device And Use Of Same | CYTOSORBENTS CORPORATION | 2025-07-10 | — | — | US | claimed |
| US-12352759-B2 | Assay method of antibody | KASHIV BIOSCIENCES, LLC (US) | 2025-07-08 | — | — | US | claimed |
| WO-2025137591-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR PROMOTING ZINC SOLUBILIZATION AND ZINC UPTAKE IN PLANTS | Tenfold Technologies, LLC (US) | 2025-06-26 | — | — | WO | claimed |
| US-20250195684-A1 | DELIVERY METHODS USING PLATELETS | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2025-06-19 | — | — | US | claimed |
| US-20220093221-A1 | SYSTEM FOR ASSESSING DRUG EFFICACY AND RESPONSE OF A PATIENT TO THERAPY | THE S.M.A.R.T. CORPORATION | 2022-03-24 | — | — | US | claimed |
| EP-3964514-A1 | GINKGOLIDE B DERIVATIVE AND SALT THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF | Huiling Jinxin (Shanghai) Pharmaceutical Technology Co., Ltd (CN) | 2022-03-09 | — | — | EP | claimed |
| WO-2022047234-A1 | DRUG COMBINATION KITS AND METHODS OF DRUG DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-03-03 | — | — | WO | claimed |
| CN-114002421-A | Application of exosome metabolite as bipolar affective disorder marker | 佛山市第三人民医院(佛山市精神卫生中心) | 2022-02-01 | — | — | CN | claimed |
| US-7973023-B2 | Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders | VASCULAR BIOGENICS LTD. (IL) | 2011-07-05 | — | — | US | claimed |
| US-7902176-B2 | Etherified oxidized phospholipids for inducing tolerance to oxidized LDL via mucosal administration; 1-hexadecyl-2-(5'-oxo-pentanyl)-sn-glycero-3-phosphocholine (D-ALLE) | VASCULAR BIOGENICS LTD. (IL) | 2011-03-08 | — | — | US | claimed |
| US-20100048515-A1 | Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders | VASCULAR BIOGENICS LTD. (IL) | 2010-02-25 | — | — | US | claimed |
| US-20080261865-A1 | Oxidized Lipids and Uses Thereof in the Treatment of Inflammatory Diseases and Disorders | VASCULAR BIOGENICS LTD. (IL) | 2008-10-23 | — | — | US | claimed |
| US-20070099868-A1 | Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders | VASCULAR BIOGENICS LTD. (IL) | 2007-05-03 | — | — | US | claimed |
| EP-0638646-B1 | Oxidized phospholipid degrading enzyme and gene thereof | SUNTORY LTD (JP) | 2001-12-19 | — | — | EP | claimed |